Condition: Head and Neck Neoplasms · Recurrent Disease · Metastatic Cancer · Sponsor: Eye & ENT Hospital of Fudan University
This trial is a multicenter, prospective, single-arm exploratory clinical study to evaluate the efficacy and safety of Penpulimab injection combined with cetuximab in the first-line treatment of recurrent/metastatic squamous cell carcinoma of the head and neck.
This description comes directly from the study's public registry record.
Xiaoshen Wang · 18917785187 · ruijin702@163.com
Always discuss trial participation with your own doctor first.
| Department of radiotherapy,The First Bethune Hospital of Jilin University | Changchun, Jilin, China | Recruiting |
| Department of Radiotherapy, Eye & ENT Hospital of Fudan University | Shanghai, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05260671